CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 89 filers reported holding CULLINAN ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $935,018 | +339.1% | 103,317 | +422.1% | 0.00% | – |
| Q2 2023 | $212,919 | -75.9% | 19,788 | -77.0% | 0.00% | – |
| Q1 2023 | $881,836 | +19.7% | 86,201 | +23.4% | 0.00% | – |
| Q4 2022 | $736,696 | -8.6% | 69,829 | +11.0% | 0.00% | – |
| Q3 2022 | $806,000 | +119.6% | 62,899 | +119.4% | 0.00% | – |
| Q2 2022 | $367,000 | -22.7% | 28,672 | -36.9% | 0.00% | – |
| Q1 2022 | $475,000 | +6.0% | 45,433 | +56.4% | 0.00% | – |
| Q4 2021 | $448,000 | +114.4% | 29,049 | +213.6% | 0.00% | – |
| Q3 2021 | $209,000 | -44.4% | 9,264 | -36.7% | 0.00% | – |
| Q2 2021 | $376,000 | -61.3% | 14,636 | -37.3% | 0.00% | – |
| Q1 2021 | $972,000 | – | 23,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $69,216,825 | 18.48% |
| CHI Advisors LLC | 3,414,189 | $30,898,410 | 12.25% |
| Nextech Invest Ltd. | 1,221,145 | $11,051,362 | 3.35% |
| TANG CAPITAL MANAGEMENT LLC | 621,138 | $5,621,299 | 0.79% |
| BVF INC/IL | 3,196,701 | $28,930,144 | 0.78% |
| Parkman Healthcare Partners LLC | 438,745 | $3,970,642 | 0.73% |
| Velan Capital Investment Management LP | 75,000 | $678,750 | 0.55% |
| BRAIDWELL LP | 1,908,865 | $17,275,228 | 0.55% |
| Boxer Capital, LLC | 1,074,082 | $9,720,442 | 0.52% |
| DAFNA Capital Management LLC | 127,284 | $1,151,920 | 0.36% |